Compounds of formula (I)
##STR00001##
wherein R.sup.1, R.sup.2, R.sup.4, and W are defined in the description
are TRPV 1 antagonists with CNS penetration. Compositions comprising such
compounds and methods for treating conditions and disorders using such
compounds and compositions are also disclosed.